当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析

瑞普生物

(300119)

  

流通市值:52.68亿  总市值:73.49亿
流通股本:3.34亿   总股本:4.66亿

瑞普生物(300119)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润5.11亿元,每股收益0.98元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益480488.59万元,未分配利润167315.15万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产659594.15万元,负债179105.56万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入2,248,962,053.981,587,164,776.49994,096,256.27442,780,482.14
营业总成本1,874,332,565.391,314,397,482.78823,889,058.32361,812,573.71
营业利润565,230,235.97326,718,407.91215,890,268.2998,534,255.21
利润总额566,680,053.37326,085,531.64215,106,348.6898,183,331.71
净利润511,016,725.18294,900,963.96193,473,91387,502,825.62
其他综合收益----
综合收益总额511,016,725.18294,900,963.96193,473,91387,502,825.62
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计3,263,327,707.083,038,546,011.312,926,085,762.652,983,122,833.86
非流动资产合计3,332,613,7943,179,957,029.923,186,502,072.133,046,768,816.44
资产总计6,595,941,501.086,218,503,041.236,112,587,834.786,029,891,650.3
流动负债合计1,344,905,393.371,140,384,582.851,101,472,258.441,147,847,165.75
非流动负债合计446,150,180.04432,322,637.83468,485,855.93296,430,404.06
负债合计1,791,055,573.411,572,707,220.681,569,958,114.371,444,277,569.81
归属于母公司股东权益合计4,496,304,113.264,360,872,233.934,263,706,325.374,304,314,100.55
股东权益合计4,804,885,927.674,645,795,820.554,542,629,720.414,585,614,080.49
负债和股东权益合计6,595,941,501.086,218,503,041.236,112,587,834.786,029,891,650.3
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计2,138,323,520.771,539,169,685.281,028,613,795.37489,240,423.96
经营活动现金流出小计1,760,127,192.171,342,202,344891,854,515.62460,028,252.11
经营活动产生的现金流量净额378,196,328.6196,967,341.28136,759,279.7529,212,171.85
投资活动现金流入小计3,817,291,917.932,756,212,231.591,943,937,110.361,266,118,689.06
投资活动现金流出小计3,978,266,527.072,596,845,145.091,940,163,160.381,215,770,213.67
投资活动产生的现金流量净额-160,974,609.14159,367,086.53,773,949.9850,348,475.39
筹资活动现金流入小计725,107,254.95500,386,754.95480,600,254.95135,100,254.95
筹资活动现金流出小计997,568,243.13851,081,798.01715,782,574.22269,385,887.04
筹资活动产生的现金流量净额-272,460,988.18-350,695,043.06-235,182,319.27-134,285,632.09
汇率变动对现金及现金等价物的影响64,250.4854,806.2942,838.5223,388.14
现金及现金等价物净增加额-55,175,018.245,694,191.01-94,606,251.02-54,701,596.71
期末现金及现金等价物余额321,529,914.7382,399,123.95282,098,681.92322,003,336.23
最新报告期:2024-04-08
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
光大证券李晓渊1.181.451.752024-04-08
华创证券陈鹏,雷轶1.131.341.492024-04-06
中金公司单妍,王思洋1.191.34--2024-04-01
华安证券王莺,万定宇1.081.421.832024-04-01
西南证券徐卿1.101.351.612024-04-01
TOP↑